Marrone bio announces cfo transition

Raleigh, n.c., feb. 22, 2022 (globe newswire) -- marrone bio innovations, inc. (nasdaq: mbii), an international leader in sustainable bioprotection and plant health solutions, announced today a transition of its chief financial officer role. current cfo sue cheung has chosen to resign for personal reasons, effective march 9, 2022. ladon johnson, a director with cfo systems, has been appointed interim cfo on a consulting basis while the company begins a national search for a permanent cfo.
MBII Ratings Summary
MBII Quant Ranking